| The International Neuroblastoma Risk Group (INRG) classification system: an INRG task force report SL Cohn, ADJ Pearson, WB London, T Monclair, PF Ambros, GM Brodeur, ... Journal of clinical oncology 27 (2), 289-297, 2009 | 2319 | 2009 |
| Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer I Versteege, N Sévenet, J Lange, MF Rousseau-Merck, P Ambros, ... Nature 394 (6689), 203-206, 1998 | 1837 | 1998 |
| The international neuroblastoma risk group (INRG) staging system: an INRG task force report T Monclair, GM Brodeur, PF Ambros, HJ Brisse, G Cecchetto, K Holmes, ... Journal of clinical oncology 27 (2), 298-303, 2009 | 1448 | 2009 |
| The Ewing family of tumors--a subgroup of small-round-cell tumors defined by specific chimeric transcripts O Delattre, J Zucman, T Melot, XS Garau, JM Zucker, GM Lenoir, ... New England Journal of Medicine 331 (5), 294-299, 1994 | 1330 | 1994 |
| Advances in risk classification and treatment strategies for neuroblastoma NR Pinto, MA Applebaum, SL Volchenboum, KK Matthay, WB London, ... Journal of clinical oncology 33 (27), 3008-3017, 2015 | 1005 | 2015 |
| MIC2 is a specific marker for Ewing's sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of Ewing's sarcoma and peripheral primitive … IM Ambros, PF Ambros, S Strehl, H Kovar, H Gadner, M Salzer‐Kuntschik Cancer 67 (7), 1886-1893, 1991 | 784 | 1991 |
| Chromosomally integrated human herpesvirus 6: questions and answers PE Pellett, DV Ablashi, PF Ambros, H Agut, MT Caserta, V Descamps, ... Reviews in medical virology 22 (3), 144-155, 2012 | 452 | 2012 |
| Interleukin 2 with anti-GD2 antibody ch14. 18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial R Ladenstein, U Pötschger, D Valteau-Couanet, R Luksch, V Castel, ... The Lancet Oncology 19 (12), 1617-1629, 2018 | 437 | 2018 |
| The latent human herpesvirus-6A genome specifically integrates in telomeres of human chromosomes in vivo and in vitro JH Arbuckle, MM Medveczky, J Luka, SH Hadley, A Luegmayr, D Ablashi, ... Proceedings of the National Academy of Sciences 107 (12), 5563-5568, 2010 | 433 | 2010 |
| hTERT alone immortalizes epithelial cells of renal proximal tubules without changing their functional characteristics M Wieser, G Stadler, P Jennings, B Streubel, W Pfaller, P Ambros, C Riedl, ... American Journal of Physiology-Renal Physiology 295 (5), F1365-F1375, 2008 | 402 | 2008 |
| Clinical and biologic features predictive of survival after relapse of neuroblastoma: a report from the International Neuroblastoma Risk Group project WB London, V Castel, T Monclair, PF Ambros, ADJ Pearson, SL Cohn, ... Journal of clinical oncology 29 (24), 3286-3292, 2011 | 382 | 2011 |
| Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi … R Ladenstein, U Pötschger, ADJ Pearson, P Brock, R Luksch, V Castel, ... The lancet oncology 18 (4), 500-514, 2017 | 363 | 2017 |
| Homology-dependent gene silencing in transgenic plants: epistatic silencing loci contain multiple copies of methylated transgenes AJM Matzke, F Neuhuber, YD Park, PF Ambros, MA Matzke Molecular and General Genetics MGG 244 (3), 219-229, 1994 | 337 | 1994 |
| Modification of DAPI banding on human chromosomes by prestaining with a DNA-binding oligopeptide antibiotic, distamycin A D Schweizer, P Ambros, M Andrle Experimental Cell Research 111 (2), 327-332, 1978 | 332 | 1978 |
| A novel putative tyrosine kinase receptor with oncogenic potential. JW Janssen, AS Schulz, AC Steenvoorden, M Schmidberger, S Strehl, ... Oncogene 6 (11), 2113-2120, 1991 | 329 | 1991 |
| Circulating breast cancer cells are frequently apoptotic G Méhes, A Witt, E Kubista, PF Ambros The American journal of pathology 159 (1), 17-20, 2001 | 316 | 2001 |
| Role of ploidy, chromosome 1p, and Schwann cells in the maturation of neuroblastoma IM Ambros, A Zellner, B Roald, G Amann, R Ladenstein, D Printz, ... New England Journal of Medicine 334 (23), 1505-1511, 1996 | 316 | 1996 |
| Gene amplification as double minutes or homogeneously staining regions in solid tumors: origin and structure CT Storlazzi, A Lonoce, MC Guastadisegni, D Trombetta, P D'Addabbo, ... Genome research 20 (9), 1198-1206, 2010 | 295 | 2010 |
| DNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma NC Sheffield, G Pierron, J Klughammer, P Datlinger, A Schönegger, ... Nature medicine 23 (3), 386-395, 2017 | 276 | 2017 |
| Application of Giemsa banding to orchid karyotype analysis T Schwarzacher, P Ambros, D Schweizer Plant systematics and evolution 134 (3), 293-297, 1980 | 271 | 1980 |
wendy londonProfessor of Pediatrics, Harvard Medical SchoolVerified email at childrens.harvard.edu
